IBRX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Immunitybio Inc

Watchlist Manager

Watchlist

Price: 6.92 USD -5.08% Market Closed

Market Cap: $7.2B

	Immunitybio Inc NASDAQ:IBRX	US
I	IDNTT SA MIL:IDNTT	CH
	Livingstone Health Holdings Ltd SGX:PRH	SG
	LG Display Co Ltd NYSE:LPL	KR
S	Sherritt International Corp XMUN:HRT	CA

Profitability Summary

Immunitybio Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Sustainable 3Y Average Gross Margin

42%

Negative Operating Margin

-226%

Negative 3Y Average Operating Margin

-30.772%

Operating Margin is Increasing

-62.186% > -226%

Negative Net Margin

-310%

Negative 3Y Average Net Margin

-46.894%

Net Margin is Increasing

-72.897% > -310%

Negative Free Cash Flow Margin

-273%

Negative 3Y Average Free Cash Flow Margin

-34.533%

Free Cash Flow Margin is Increasing

-68.836% > -273%

Exceptional ROE

71%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-147%

ROIC is Increasing

-181% > -107%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.